TP53 and head and neck cancer: In order to obtain useful information on the most efficient therapeutic approach in head and neck cancers, we analyzed the effect of treatment with RSV on the response induced by CisPt treatment on FaDu tumor cells that have a point mutation of TP53 [70] compared to PE/CA-PJ49 tumor cells that have no mutations of the TP53 gene.